Replies to post #473 on Repros Therapeutics Inc (RPRX)

[Nerf]

According to IMS Health data, 2005 US sales of Androgel 1% totaled $330 million.


http://www.tradingmarkets.com/.site/news/TOP%20STORY/403996/

This is only their "oh by the way we've got this other one too, androxal, it's called. our biggie is proellex"

At current valuation, an approval of Androxal with subsequent sale might just be worth the whole company!